My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

AdvisorShares Psychedelics ETF (NY:PSIL)

19.28 +0.83 (+4.48%)

Streaming Delayed Price Updated: 12:11 PM EST, Nov 28, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about AdvisorShares Psychedelics ETF

< Previous 1 2 3 4 5 Next >

Psyched: Germany Ships LSD Prodrugs Via DHL, Minneapolis Decriminalizes, Wiz Khalifa's Magic Pitch & More ↗

July 24, 2023

Minneapolis Mayor Deprioritizes Psychedelics: 'We Should Be In The Business Of Helping People' Minneapolis Mayor Jacob Frey recently signed an executive order effectively deprioritizing criminal...

Via Benzinga

These 9 Fringe ETFs Have Outperformed The S&P 500 And Nasdaq ↗

July 23, 2023

There are 9 ETFs that overlap our portfolios of the cannabis, psychedelic, Bitcoin, AI,

Via Talk Markets

Psyched: NDAA Amendments Blocked, National Practitioners Network, Marijuana In Jackie Kennedy's Garden And More ↗

July 19, 2023

GOP-Controlled House Committee Blocks All Cannabis & Psychedelics Amendments To Defense Bill: Now, No Floor Vote

Via Benzinga

These 8 Fringe ETFs Are Up 5% On Average MTD ↗

July 17, 2023

Consider buying one of these 8 ETFs if you are interested in any of the cannabis, psychedelic, cryptocurrency, AI,

Via Talk Markets

Psychedelic Compound-Based Drug Stocks Up 12% MTD; Now Up 25% YTD ↗

July 14, 2023

Our Psychedelic Drug Stocks Index is up 12.3% MTD and is now up 25.1% YTD.

Via Talk Markets

Psyched: Australia's Innovative Program, Congressional Amendments, Therapy Reimbursement And More ↗

July 11, 2023

First Country Allowing MDMA & Psilocybin For Depression, PTSD Makes Headlines On Saturday, July 1, 2023, Australia became the first country to allow physicians to prescribe MDMA to treat post-traumatic...

Via Benzinga

These 8 Fringe ETF Returns Ranged From +13% To -5% Last Week ↗

July 11, 2023

If you are interested in any of the cannabis, psychedelic, cryptocurrency, artificial intelligence,

Via Talk Markets

Psychedelic Stocks Jumped 10% Last Week ↗

July 09, 2023

The FDA released a positive draft guidance for developing psychedelic treatments and the 6 largest stocks in the Psychedelic Drug Stocks Index responded accordingly

Via Talk Markets

Check Out These 8 Fringe ETFs ↗

July 04, 2023

If you are bullish on any of the cannabis, psychedelic, cryptocurrency, artificial intelligence (AI),

Via Talk Markets

Psyched: A $100M Donation Pledge, Frank Biden Gets Candid, New Search Trends & More ↗

July 04, 2023

World's Largest Psychedelics Conference Boasts 12K Attendees

Via Benzinga

Upward Trend In Largest Psychedelic Compound-Based R&D Stocks Continues ↗

July 01, 2023

Our Psychedelic Drug Stocks Index, which consists of the 6 largest psychedelic compound-based research & development companies, was up 3.4% this week, up 7.1% in June, up 6.3% in May, and is now up...

Via Talk Markets

Psyched: Dubai Psychedelics Event, Key Receptor Discovered, Drew Barrymore, Oprah's Guest, Swiss MDMA & More ↗

June 13, 2023

Science Conference In Dubai, UAE Hosts Discussion On Psychedelics Research

Via Benzinga

Major Psychedelic Compound-Based Research & Development Stocks: June Update ↗

June 10, 2023

Psychedelic Drug Stocks Index has been revamped with the removal of Cybin (CYBN) which has dropped below $100M in market capitalization leaving 6 constituents in the Index

Via Talk Markets

Psyched: Millions From Institutional Investor And Fed Funding For Research, M&As, Women Veterans And More ↗

June 06, 2023

Major Investor Commits $30 Million To Psychedelics Funding

Via Benzinga

Psyched: LSD Microdosing For Depression, DMT For Anxiety, MDMA Octopuses And More ↗

May 31, 2023

Microdosing LSD For Major Depression Treatment Seeks Further Clinical Validation Via New Study Australian psychedelics company MindBio Therapeutics Corp. was granted approval by both the Ethics...

Via Benzinga

Psyched: New Psilocybin Forms, LSD Anxiety Study, UK's Parliamentary Debate And More ↗

May 23, 2023

Biotech Company Discovers What May Be The First New Compounds Of Psilocybin In History NY-based biotech platform Terran Biosciences announced the publication of an international PCT patent application...

Via Benzinga

Psyched: $20M Research Fund, LSD Microdosing For Cancer, MEAI Enters Clinical Stage, Reform Update & More ↗

May 15, 2023

Researchers At Johns Hopkins Get $20M Fund Prompted By Longtime Psychedelics Scientist Johns Hopkins University academics received a boost in funding thanks to the recently launched Roland R. Griffiths...

Via Benzinga

Psyched: Psychedelics Reimbursement, Amanita Muscaria Boom, $53M Material Breach Lawsuit & More ↗

May 08, 2023

EXCLUSIVE: AMA Moves Toward Psychedelic Therapy Reimbursement, Filing A Gap In Regulations

Via Benzinga

Psyched: Oregon And Colorado Regulations, MindMed CEO Discusses LSD Therapy, Mia Khalifa Enters Market & More ↗

May 01, 2023

Oregon Pioneers Legal Psilocybin Therapy, But This Type Of License Has Yet To Be Issued

Via Benzinga

Psyched: LSD For Major Depression, Canada's Psilocybin Macrodose Trial, Treatments For Multiple Sclerosis And More ↗

April 24, 2023

LSD Trial Study Shows Potential For Major Depression Psychedelics biopharma company Mind Medicine Inc. (NASDAQ: MNMD) recently shared positive topline data from an advanced clinical trial of LSD as a...

Via Benzinga

ETFs Outperforming The S&P 500, On Average ↗

April 18, 2023

If you are bullish on any of the cannabis, psychedelic, cryptocurrency, or gold and silver junior miner categories then consider buying these six ETFs.

Via Talk Markets

Psyched: Clinical-Grade MDMA, LSD For Depression, Partnerships For Delivering Psychedelic Therapies & More ↗

April 17, 2023

Revolutionizing Psychedelics: 2 Industry Leaders Team Up On Clinical-Grade MDMA Capsules

Via Benzinga

EXCLUSIVE: Investing In The Unique Growth Market Of Psychedelics ↗

April 13, 2023

The global psychedelics market of drugs such as psilocybin, ketamine and LSD is booming and there are plenty of ways to get involved in the space.

Via Benzinga

Psyched: MDMA Therapy Advances With FDA, Alternatives For Alcohol Addiction, Prince Harry In The Spotlight And More ↗

April 11, 2023

MDMA Therapy For PTSD Nearing Legalization In U.S. And Worldwide, MAPS Releases Promising Data

Via Benzinga

"Multi-Bagger" Portfolio Down 13% In March; Still Up Almost 6% YTD ↗

April 04, 2023

The

Via Talk Markets

What To Expect From The Benzinga Psychedelics Capital Conference, The Must-Attend Event For This Emerging Industry ↗

April 03, 2023

The world of psychedelics is evolving rapidly, and the Benzinga Psychedelics Capital Conference is the premier event for those who want to be part of this exciting journey.

Via Benzinga

Our Aggressive ETF Portfolio Is Outperforming The S&P 500 By A 2-To-1 Margin ↗

April 03, 2023

Our Aggressive ETF Portfolio consists of 6 ETFs containing some downtrodden categories: cannabis MSOs and LPs, psychedelic stocks, cryptocurrency futures, and junior gold and silver miners.

Via Talk Markets

Psyched: Australia As Psychedelics Hub, Advanced Scans Of Brain On DMT, New PAC For Congressional Influence, 9 States Advancing Bills & More ↗

March 27, 2023

Australia: Enveric, FSD Pharma, Psyence & Others Advance Businesses

Via Benzinga

An Aggressive ETF Portfolio For 2023: An Update ↗

March 21, 2023

If you are bullish on any of the cannabis, psychedelic, cryptocurrency, or gold and silver junior miner categories, take a look at these ETFs.

Via Talk Markets

Psyched: 22 States With Reform Bills, Ketamine Therapy Services Today, Oscars On Shrooms & More ↗

March 20, 2023

Psychedelics Reform Update: 22 States Where Proposals Are Being Discussed & Local Moves Considered

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.